Inflammatory processes in amyotrophic lateral sclerosis.
about
Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repairExpression and localization of cyclooxygenase-1 and -2 in human sporadic amyotrophic lateral sclerosisThe CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onsetDifferential modulation of microglia superoxide anion and thromboxane B2 generation by the marine manzaminesSignaling pathways mediating a selective induction of nitric oxide synthase II by tumor necrosis factor alpha in nerve growth factor-responsive cellsIs spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?Neuroprotective and symptomatic effects of targeting group III mGlu receptors in neurodegenerative diseaseGap junctions and hemichannels composed of connexins: potential therapeutic targets for neurodegenerative diseasesTherapeutic neuroprotective agents for amyotrophic lateral sclerosisBlood-CNS Barrier Impairment in ALS patients versus an animal modelBlockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's diseaseTargeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice.Astrocytes and Microglia as Non-cell Autonomous Players in the Pathogenesis of ALSSystems biology of neurodegenerative diseasesThe complex molecular biology of amyotrophic lateral sclerosis (ALS)Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesInterleukin-1 Antagonist Anakinra in Amyotrophic Lateral Sclerosis--A Pilot StudyMultiple intravenous administrations of human umbilical cord blood cells benefit in a mouse model of ALSReduction of circulating endothelial cells in peripheral blood of ALS patientsMechanisms underlying inflammation in neurodegenerationOligomerization of Cu,Zn-Superoxide Dismutase (SOD1) by Docosahexaenoic Acid and Its Hydroperoxides In Vitro: Aggregation Dependence on Fatty Acid Unsaturation and Thiols.Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms.Sporadic amyotrophic lateral sclerosis: a hypothesis of persistent (non-lytic) enteroviral infection.Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose.Proteomic analysis of plasma from Portuguese patients with familial amyotrophic lateral sclerosis.Nordihydroguaiaretic acid increases glutamate uptake in vitro and in vivo: therapeutic implications for amyotrophic lateral sclerosisAdaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice.Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.Activin A is essential for neurogenesis following neurodegenerationLead optimization studies of cinnamic amide EP2 antagonistsDeregulated expression of cytoskeleton related genes in the spinal cord and sciatic nerve of presymptomatic SOD1(G93A) Amyotrophic Lateral Sclerosis mouse model.Prostanoid receptor EP2 as a therapeutic targetEvidence for an early innate immune response in the motor cortex of ALS.Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases.Complex genetics of amyotrophic lateral sclerosis.NP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker studyNonsteroidal anti-inflammatory drugs differentially affect the heat shock response in cultured spinal cord cells.SOD1(G93A) transgenic mouse CD4(+) T cells mediate neuroprotection after facial nerve axotomy when removed from a suppressive peripheral microenvironment.
P2860
Q21284516-DB2227C0-289B-4833-8C60-5C4985028055Q24295307-27AD3622-F086-46F8-9B61-EB34721E06CBQ24650098-CE2FA39D-7542-4559-9B44-9DFDF525EC3FQ24794827-34864582-7297-4109-9B61-CB591AC29602Q24814434-5FBE45F2-64E7-457F-8BE7-3596BC462649Q26774987-9B5FB6A1-91F5-4A5A-B4E4-74BAA791D7EDQ26799233-784BEB2B-48EF-4E23-8227-018A21B92A82Q26861263-A5E142F8-FA73-4302-8D4B-4DFD31FC1EE3Q26995351-B1D1409C-E997-4D8D-9A57-C801D0C6C7DDQ27012316-09CC6E66-D75C-4542-910E-06889ED24AF6Q27015029-961447A8-5B38-40C2-8E9C-0A679436D3B9Q27026792-E8D770DF-AF06-4BFE-A68E-0379898E14A0Q27334874-289FAE58-078F-46BD-BE43-BCDB685DEC69Q27340206-0D105576-9DDC-4DF2-B89E-EFCBB6589C46Q28078651-A92E05D5-6A5F-4CB1-87FA-4C11C1B29ACAQ28080741-A1496DBD-B1ED-419B-8DCC-D59D2946CB62Q28263899-785F99F1-A335-48FF-BF8F-B6E4C7B9F1D7Q28388335-CC692514-52A3-4643-AE03-C5D1F1E32FDBQ28550089-A4996D47-3212-4F64-92A1-4CF834EBDA75Q28732245-02895947-CFEB-4BD8-9C60-71B418D16BE1Q28752226-526D199A-E428-440B-870D-5146DBB23EE1Q29617977-306BE743-3886-4885-814C-F3ECF90A7ACCQ30374274-2FAAC639-3CD7-4278-89CB-B3871DA5BC0DQ30552760-A5DBE6CA-476A-439F-A18E-9FCE76A63EE6Q33220088-1523FF96-D526-4E34-90E5-3954E5DD6979Q33346297-9CA872CB-225F-415D-A04C-B19795D9439BQ33349895-639A1F1E-7429-4BA6-A4DF-FF8A34D9576AQ33351549-7BAFA7A2-98E3-4A46-8C81-44EE4F97D64BQ33354106-AD3FC91A-EF7A-4FCD-89BB-41255D9FADBFQ33361835-A49A29F6-CCFC-4101-898F-63EFF57F20B6Q33458604-CA48BC8A-E70F-4282-A1A7-D08D2E88EBE7Q33654575-09E3DEFF-36C1-4574-9720-8B35C99AD07EQ33659976-04106A8D-01E1-4332-81FC-4FBBE27BFAACQ33711678-0DC707F6-16CD-45BE-8BCF-442B27240951Q33837511-AD233DF2-A506-4521-AFFC-407AFFBA0D2FQ33891870-37492412-2C39-457C-B7C9-01381D109B41Q33910597-ACD1285A-4E8E-4670-98A2-68B55036CA92Q33924917-75E648DF-207D-4EE9-8A60-00061C84AA27Q34020316-6CBDDB07-0294-4CFF-971B-A86C95F2324FQ34040293-DAE03CCE-F1C4-44DC-B337-B80BAD537B1B
P2860
Inflammatory processes in amyotrophic lateral sclerosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Inflammatory processes in amyotrophic lateral sclerosis.
@ast
Inflammatory processes in amyotrophic lateral sclerosis.
@en
Inflammatory processes in amyotrophic lateral sclerosis.
@nl
type
label
Inflammatory processes in amyotrophic lateral sclerosis.
@ast
Inflammatory processes in amyotrophic lateral sclerosis.
@en
Inflammatory processes in amyotrophic lateral sclerosis.
@nl
prefLabel
Inflammatory processes in amyotrophic lateral sclerosis.
@ast
Inflammatory processes in amyotrophic lateral sclerosis.
@en
Inflammatory processes in amyotrophic lateral sclerosis.
@nl
P356
P1433
P1476
Inflammatory processes in amyotrophic lateral sclerosis.
@en
P2093
P304
P356
10.1002/MUS.10191
P577
2002-10-01T00:00:00Z